Meihua International Medical Technologies
MHUA
MHUA was delisted on the 8th of December, 2025.
2 hedge funds and large institutions have $71K invested in Meihua International Medical Technologies in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$49.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$6.85K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $62K | +$49.8K | +109 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $9K | +$6.85K | +15 | New |
|
MHUA Hedge Fund Activity: Q3 2022 in Review
2 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Meihua International Medical Technologies (MHUA) for Q3 2022, worth a combined $71K.
Buyers outnumbered sellers: 2 funds opened new MHUA positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $49.8K.
- 2 institutional investors held Meihua International Medical Technologies (MHUA) as of Q3 2022, up from 0 in Q2 2022.
- Funds reported $71K of Meihua International Medical Technologies stock for Q3 2022.
- 2 funds opened new Meihua International Medical Technologies positions in Q3 2022 and 0 closed out, a net change of +2 holders.
- The largest Meihua International Medical Technologies buyer in Q3 2022 was Susquehanna International Group, an estimated $49.8K added.
Based on aggregated 13F filings for Q3 2022.